Funder: The Mark Foundation for Cancer Research
Due Dates (Anticipated): January 2026 (LOI – ASPIRE Award: Glioblastoma RFP) | February 2026 (LOI – ASPIRE Award: Intrinsically Disordered Proteins & Cancer RFP)
Funding Amounts: Up to $250,000 for 1 year (standard); up to $500,000 for clinical studies; larger/longer awards by invitation only.
Summary: Supports innovative, high-risk projects that address major challenges in cancer research, from basic mechanisms to translational and clinical studies.
Key Information: All deadlines are projected; confirm details on the program page before applying.